Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-807-1 | CAS number: 542-28-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The test item was tested for mutagenicity in the Ames test and in the E. coli- reverse mutation assay both in the plate incorporation test and in the preincubation test with and without the addition of a metabolizing system obtained from rat liver (S-9 mix) using the Salmonella strains TA 1535, TA 100, TA 1537, TA 98 and Escherichia coli WP2 uvrA at a dose range of 20-5000 µg/plate (GLP guideline study, BASF AG, 1998). Positive control substances caused increases in the number of revertants as expected, indicating proper test conditions. The test substance showed no mutagenic effects at any dose level including the recommended limit dose of 5000 µg/plate.
Chromosome Aberration Test in V79 Cells
In a mammalian cell cytogenetics assay (Harlan CCR, 2012), V79 cell cultures were exposed to Delta-Valerolactone at concentrations of 0, 128.8, 257.5, 515.5 or 1030.0 µg/mL with metabolic and 0, 257.5, 515.0, 772.5, 901.5 or 1030.0 µg/mL without metabolic activation (Phenobarbital/beta-Naphtoflavone induced rat liver S9). Delta-Valerolactone was tested up to a concentration equal to approximately 10 mM, the recommended highest concentration for freely-soluble test items. Positive controls induced the appropriate response. There was no evidence of chromosome aberrations induced over background. This study is classified as acceptable.
HPRT Test in V79 Cells
In a mammalian cell gene mutation assay (Harlan CCR, 2012), V79 cells cultured in vitro were exposed to Delta-Valerolactone at concentrations of 0, 64.4, 128.8, 257.5, 515.0 or 1030.0 µg/mL in the presence and absence of mammalian metabolic activation (Phenobarbital/beta-Naphtoflavone induced rat liver S9). Delta-Valerolactone was tested up to a concentration equal to approximately 10 mM, the recommended highest concentration for freely-soluble test items. The positive controls did induce the appropriate response. There was no evidence of induced mutant colonies over background. This study is classified as acceptable.
Short description of key information:
The test substance was not mutagenic in a bacterial reverse mutation assay in Salmonella and E.coli (OECD 471, Ames).
The test substance was non-clastogenic in the Chromosome Aberration Test (OECD 473, In vitro Mammalian Chromsome Aberration Test).
The test substance was non-mutagenic in the HPRT assay (OECD 476, In vitro Mammalian Cell Gene Mutation Test).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Classification for mutagenicity is not warranted according to the criteria of EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
